- This group includes the glaucoma that developed for the second time due to endocrine and cardiovascular diseases. Most often this occurs as a result of complications of diabetes: diabetic retinopathy and retinal vascular occlusive lesions on the background of atherosclerosis and hypertension. As a result of the fact that in The neogenic vessels that appear in the iris and in the corner of anterior chamber and prevent the outflow of intraocular fluid, cause the rise of eye pressure, the patients complain of severe pain and rapidly progressive decrease of vision.

  - In fact, the widely used medicamental and traditional surgical methods of treatment proved ineffective. In any case, the state of patients is worsening daily. Quite often an operation to remove the eyeball was the only way to alleviate their suffering.

Meanwhile, the situation has got to change in recent years. The science proposed new methods of treatment using all kinds of drainage systems. They yield good results. However, there are technical difficulties in implementing them, there is a possibility of postoperative complications. Their high cost is a significant drawback. Our method of deep sclerectomy with implantation of xenocollagen drainage in patients with neovascular glaucoma has become the solution. It was developed by me in collaboration with Zafar Sidikov, Tatiana Savranova and Vahid Rozukulov.

- Such explicit statements are not appropriate in medicine. I can only ascertain that the results of using our technology in the hospital of the Republican Specialized Center of Eye Microsurgery have shown that this method allows achieving stable and good results in decreasing intraocular pressure and preserving visual function. The outcomes we have obtained are enough to distribute thin know-how in other eye clinics of the country.

- This is an innovative approach to the development of new ways of outflow of intraocular fluid that prevent scarring of filtration area, and implantation of special xenocollagen drainage. The method was patented last year.

- We use the xenocollagen drainage that was designed and manufactured by the Moscow Eye Center Vostok-Prozrenie. We chose this material because it is not toxic and does not cause an inflammatory reaction of surrounding tissues, and it is capable to remain its structure under the influence of natural biological processes in the body.

- The method is moving further to the regions. Our technology has been already developed by our colleagues in Khorazm branch. Demonstrative operations and training seminars were held in Namangan, Andijon and Bukhoro. I think we will soon organize them in other parts of the country.

ut file

MD, Professor Muyassar Karimova graduated from Tashkent Medical Institute in 1988. She defended her PhD thesis in 1998, and doctoral thesis - in 2004. Medical activities are combined with scientific, educational, and administrative work. She is the Deputy Director on Research at the Republican Specialized Center of Eye Microsurgery and Professor at Ophthalmology Department of Tashkent Medical Academy.